Stratos Wealth Partners, Ltd. Mannkind Corp Transaction History

Stratos Wealth Partners, Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	BUY	$2.62 - $4.45 $86 - $146	33 Added 0.29%	11,480 $42,000
Q4 2021 Jan 14, 2022	SELL	$4.05 - $5.37 $1,591 - $2,110	-393 Reduced 3.32%	11,447 $50,000
Q2 2021 Jul 19, 2021	SELL	$3.61 - $5.45 $1,913 - $2,888	-530 Reduced 4.28%	11,840 $65,000
Q4 2020 Jan 29, 2021	BUY	$1.79 - $4.04 $1,727 - $3,898	965 Added 8.46%	12,370 $39,000
Q2 2020 Jul 28, 2020	SELL	$0.94 - $2.21 $846 - $1,989	-900 Reduced 7.31%	11,405 $20,000
Q4 2019 Jan 29, 2020	SELL	$1.14 - $1.49 $1,641 - $2,145	-1,440 Reduced 10.48%	12,305 $16,000
Q3 2019 Nov 12, 2019	SELL	$1.04 - $1.44 $14,502 - $20,080	-13,945 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$1.04 - $1.44 $14,294 - $19,792	13,745 New	13,745 $17,000
Q2 2019 Aug 06, 2019	BUY	$1.09 - $1.88 $555 - $958	510 Added 3.8%	13,945 $16,000
Q4 2018 Feb 08, 2019	BUY	$1.02 - $2.05 $816 - $1,639	800 Added 6.33%	13,435 $14,000
Q3 2018 Nov 02, 2018	SELL	$1.01 - $2.19 $808 - $1,752	-800 Reduced 5.95%	12,635 $23,000
Q2 2018 Aug 13, 2018	BUY	$1.59 - $2.38 $381 - $571	240 Added 1.82%	13,435 $26,000
Q3 2017 Nov 07, 2017	BUY	$1.15 - $2.29 $15,174 - $30,216	13,195	13,195 $29,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.